Brown & Brown Inc is a diversified insurance agency, wholesale brokerage, insurance programs, and service... Show more
Brown & Brown (BRO) stock has navigated choppy waters in recent weeks, reflecting broader pressures on insurance brokerage firms. Shares have staged a partial recovery from near 52-week lows, buoyed by anticipation surrounding upcoming quarterly results, yet remain well below prior peaks amid year-to-date weakness. Trading volumes have been moderate, with the stock exhibiting lower volatility compared to the broader market, as indicated by its beta below 1.0. Market capitalization hovers around $23 billion, underscoring the company's scale in retail and wholesale insurance intermediation. Investor sentiment balances growth potential from commission revenues against macroeconomic headwinds like interest rate dynamics and claims trends.
Tickeron’s Trending AI Robots page showcases the top 25 performers curated from over 350 AI trading bots that analyze thousands of tickers across diverse strategies and timeframes. These bots deliver real-time signals for copy trading, boasting impressive stats such as annualized returns ranging from +15.50% to +177.85%, win rates between 48.48% and 87.72%, and profit factors from 1.50 to 11.70. Average trade durations span from 16 hours to 55 days, with profit-to-drawdown ratios up to 21.49. Targeting sectors like semiconductors, industrials, energy, and finance—including bots focused on investment banks and brokers—these tools adapt to current market conditions with varying ticker sets from 3 to 25 per bot. Explore these high-performing options to enhance your trading approach tailored to today’s volatility.
In the past 30 days, Brown & Brown (BRO) stock has been influenced by a mix of analyst updates, executive changes, and pre-earnings positioning, contributing to modest gains amid ongoing pressure from a steep yearly decline. Shares rose about 3.35% over the recent month, outperforming or underperforming peers on select days, as investors weighed valuation against growth prospects.
Analyst activity dominated headlines, with several firms adjusting price targets downward while maintaining neutral to positive ratings. On April 14, BofA Securities reiterated a hold rating but cut its target to $88 from prior levels; Mizuho followed suit, lowering to $84 from $85 but keeping a buy recommendation. Earlier, around April 9, JP Morgan reduced its target to $85 from $91, Wells Fargo to $72, and RBC Capital initiated coverage with a hold. These tweaks reflect caution over near-term execution amid softer insurance market dynamics, yet the consensus average target stands at approximately $79-$82 from 21 analysts, suggesting potential upside from current levels near $67.
Building anticipation for Q1 2026 earnings, scheduled for release after market close on April 27 with a conference call the next day, has also shaped sentiment. Wall Street anticipates revenues of $1.87-$1.915 billion, a 33%+ year-over-year increase, and EPS of $1.36-$1.39, driven by commission growth and prior acquisition integrations. Zacks analysis highlights BRO's history of beating estimates, potentially fueling a post-earnings move, though consensus EPS estimates dipped slightly by 2-3% in recent weeks.
Operationally, the company strengthened its leadership on April 14 by appointing Eileen Akerson as chief legal officer, signaling continuity in governance amid expansion efforts. SEC filings included an 8-K on April 9 for material events and a Schedule 13G/A on March 26, though no major M&A (mergers and acquisitions) announcements emerged. Valuation discussions noted the stock's attractiveness after a 40%+ drop from peaks, with metrics like P/E at 21 signaling relative cheapness versus historical norms.
These factors have kept trading focused, with options activity signaling expected volatility around earnings. Overall, sentiment tilts toward cautious optimism, linking price stabilization to delivery on growth narratives in brokerage commissions and fees.
As Brown & Brown progresses through 2026, investors should track several strategic elements shaping its trajectory in the insurance brokerage sector. Core revenue drivers like organic commission growth, tied to premium rate trends and policy renewals, remain pivotal amid potential market hardening or softening influenced by catastrophe losses and economic conditions. The firm's track record of disciplined M&A (mergers and acquisitions) activity could sustain expansion, integrating new retail and wholesale capabilities while managing integration costs.
Regulatory scrutiny on broker commissions and antitrust in consolidations warrants attention, alongside competitive positioning against peers like Marsh & McLennan. Macro factors such as interest rates impacting investment income and claims inflation will influence margins. Technological shifts toward digital underwriting and AI-driven risk assessment present opportunities for efficiency gains. Balanced against these are risks from cyclical insurance cycles and talent retention in a competitive labor market. Monitoring quarterly guidance updates, particularly post-Q1 results, will provide clarity on internal growth rates and fee-based revenue momentum.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
BRO moved above its 50-day moving average on June 23, 2026 date and that indicates a change from a downward trend to an upward trend. In of 32 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 23, 2026. You may want to consider a long position or call options on BRO as a result. In of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The 10-day moving average for BRO crossed bullishly above the 50-day moving average on June 25, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BRO advanced for three days, in of 342 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 309 cases where BRO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BRO broke above its upper Bollinger Band on June 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BRO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.568) is normal, around the industry mean (6.317). P/E Ratio (18.971) is within average values for comparable stocks, (27.116). BRO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.541). Dividend Yield (0.011) settles around the average of (0.016) among similar stocks. P/S Ratio (3.034) is also within normal values, averaging (2.962).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of insurance brokerage services and casualty insurance underwriting services
Industry InsuranceBrokersServices